Medpace (MEDP) a scientifically-driven, global, full-service clinical contract research organization (CRO) known for its strong scientific expertise, announced the addition of two physicians to its medical leadership team. Medpace’s unique, scientifically-driven approach to clinical research embeds medical expertise throughout trial design and execution, providing a high-science approach to clinical development. With the addition of these highly-qualified physicians, Medpace can offer Sponsors even deeper expertise across a broad spectrum of diseases and technologies.
About Phillip Cole, MD
Dr. Cole is board certified in Internal Medicine and Infectious Diseases. He has extensive experience as a medical director working with innovative biopharma companies including Amplyx Pharmaceuticals, Regulus Therapeutics, Medivation and Cerexa where he provided medical leadership developing products in antibacterials, antifungals, rare diseases, and solid organ oncology. In his roles, he provided medical oversight for numerous clinical studies across all phases as well as natural history, registry, and extension studies. Dr. Cole received his Bachelor of Science in Biochemistry & Cell Biology and a Bachelor of Arts in History from the University of California San Diego, and received his Doctor of Medicine degree from the University of California, San Francisco.
About Adaline N. Dave, MD
Dr. Adaline Dave is a clinical research physician with more than 16 years of experience in healthcare and pharmaceutical industry. She supports global and regional teams by providing medical management of clinical trials Phase I-IV in the Asia pacific region. She has significant experience in women’s health, immunology, infectious diseases, neurosciences and oncology, including key contributions in the development of novel investigational products from pre-IND to post-approval, as well as in investigator networks, feasibility, and medical informatics. Dr. Dave is a licensed physician, having received her Doctor of Medicine degree from the University of the City of Manila, Philippines.